Defunct Company
Total Trials
12
As Lead Sponsor
8
As Collaborator
4
Total Enrollment
2,815
NCT00447590
Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents
Phase: N/A
Role: Lead Sponsor
Start: Mar 31, 2007
Completion: Jun 30, 2013
NCT00501085
LAP-BAND AP Early Experience Trial (APEX)
Start: Jun 30, 2007
Completion: Nov 30, 2013
NCT00570505
Effectiveness and Safety Study of LAP-BAND Treatment in Subjects With BMI >/= 30 kg/m2 and < 40 kg/m2
Start: Nov 30, 2007
NCT00730327
A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects
Start: Jun 30, 2008
Completion: Oct 31, 2011
NCT00953173
HERO Study: Helping Evaluate Reduction in Obesity
Start: Dec 31, 2009
Completion: Oct 31, 2016
NCT01322737
Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System
Role: Collaborator
Start: Jan 31, 2011
Completion: Jun 30, 2011
NCT01307813
Apollo Overstitch, a Treat and Resect Model
Start: Feb 28, 2011
Completion: Nov 30, 2011
NCT01662024
Endoscopic Suturing for Primary Obesity Treatment
Start: Feb 28, 2013
Completion: Apr 30, 2016
NCT02356614
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study
Start: Mar 31, 2015
Completion: Mar 8, 2018
NCT02828657
ORBERA™ Post-Approval Study
Start: Jun 30, 2016
Completion: Dec 31, 2019
NCT03776188
Endoscopic Suturing (ES) Registry
Start: Oct 29, 2018
Completion: Nov 30, 2021
NCT04362774
ORBERA365 Post-Marketing Clinical Follow-up Study
Start: Feb 23, 2021
Completion: Oct 10, 2023